Last updated: September 7, 2023
Sponsor: First Affiliated Hospital of Chongqing Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Rheumatoid Arthritis
Joint Injuries
Treatment
diagnosis of Interstitial lung disease
Clinical Study ID
NCT06036537
1stChongqingMU123
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of rheumatoid arthritis patients based on the 2010 ACR/EULAR RA classificationcriteria; 2. age ≥18 years; 3. Interstitial lung disease was diagnosed by lung highresolution computed tomography (HRCT)
Exclusion
Exclusion Criteria:
- age <years; 2. Being treated with urate-lowering medications; 3. Other systemic/organspecific autoimmune diseases other than rheumatoid arthritis (such as SLE, ANCA associatedvasculitis, pSS, SSc, myositis, etc.); 4.Tumor, pulmonary tuberculosis, glomerularfiltration rate less than 30ml/min/1.73m2
Study Design
Total Participants: 1200
Treatment Group(s): 1
Primary Treatment: diagnosis of Interstitial lung disease
Phase:
Study Start date:
June 01, 2023
Estimated Completion Date:
June 30, 2025
Connect with a study center
Chongqing General Hospital
Chongqing, Chongqing 401147
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.